Luo HH - Search Results

1

Exploring the relationship between the interleukin family and lung adenocarcinoma through Mendelian randomization and RNA sequencing analysis.

Zhi FH, Liu W, Yang HS, Luo HH, Feng YF, Lei YY. Zhi FH, et al. Among authors: luo hh. Discov Oncol. 2024 Sep 12;15(1):436. doi: 10.1007/s12672-024-01325-1. Discov Oncol. 2024. PMID: 39264458 Free PMC article.

2

Methylation of N6 adenosine-related long noncoding RNA: effects on prognosis and treatment in 'driver-gene-negative' lung adenocarcinoma.

Yang HS, Cai HY, Shan SC, Chen TF, Zou JY, Abudurufu M, Luo HH, Lei YY, Ke ZF, Zhu Y. Yang HS, et al. Among authors: luo hh. Mol Oncol. 2023 Feb;17(2):365-377. doi: 10.1002/1878-0261.13323. Epub 2022 Nov 16. Mol Oncol. 2023. PMID: 36221911 Free PMC article.

3

Hypothyroidism reduces the risk of lung cancer through oxidative stress response and the PI3K/Akt signaling pathway: An RNA-seq and Mendelian randomization study.

Liu W, Zhi FH, Zheng SY, Yang HS, Geng XJ, Luo HH, Feng YF, Lei YY. Liu W, et al. Among authors: luo hh. Heliyon. 2023 Nov 22;9(12):e22661. doi: 10.1016/j.heliyon.2023.e22661. eCollection 2023 Dec. Heliyon. 2023. PMID: 38107290 Free PMC article.

4

A novel signature based on immune-related gene pairs and clinical features to predict prognosis and treatment effect in "driver gene negative" lung adenocarcinoma.

Cai HY, Yang HS, Shan SC, Lei YY, Zou JY, Zhu Y, Luo HH. Cai HY, et al. Among authors: luo hh. Cancer Med. 2022 Jun;11(11):2259-2270. doi: 10.1002/cam4.4577. Epub 2022 Mar 4. Cancer Med. 2022. PMID: 35246970 Free PMC article.

5

A Novel Ras--Related Signature Improves Prognostic Capacity in Oesophageal Squamous Cell Carcinoma.

Yang HS, Liu W, Zheng SY, Cai HY, Luo HH, Feng YF, Lei YY. Yang HS, et al. Among authors: luo hh. Front Genet. 2022 Feb 24;13:822966. doi: 10.3389/fgene.2022.822966. eCollection 2022. Front Genet. 2022. PMID: 35281814 Free PMC article.

6

Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.

Liu W, Yang HS, Zheng SY, Weng JH, Luo HH, Lei YY, Feng YF. Liu W, et al. Among authors: luo hh. BMC Genomics. 2022 Sep 16;23(1):656. doi: 10.1186/s12864-022-08880-3. BMC Genomics. 2022. PMID: 36114454 Free PMC article.

7

Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.

Liu W, Yang HS, Zheng SY, Luo HH, Feng YF, Lei YY. Liu W, et al. Among authors: luo hh. BMC Bioinformatics. 2022 Sep 30;23(1):406. doi: 10.1186/s12859-022-04956-9. BMC Bioinformatics. 2022. PMID: 36180848 Free PMC article.

8

Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas.

Liu W, Yang HS, Zhi FH, Feng YF, Luo HH, Zhu Y, Lei YY. Liu W, et al. Among authors: luo hh. Clin Transl Med. 2023 Oct;13(10):e1368. doi: 10.1002/ctm2.1368. Clin Transl Med. 2023. PMID: 37784249 Free PMC article.

9

Aurora-A is a novel predictor of poor prognosis in patients with resected lung adenocarcinoma.

Zeng B, Lei Y, Zhu H, Luo S, Zhuang M, Su C, Zou J, Yang L, Luo H. Zeng B, et al. Chin J Cancer Res. 2014 Apr;26(2):166-73. doi: 10.3978/j.issn.1000-9604.2014.04.08. Chin J Cancer Res. 2014. PMID: 24826057 Free PMC article.

10

Effect of mir-16 on proliferation and apoptosis in human A549 lung adenocarcinoma cells.

Gu Y, Wang XD, Lu JJ, Lei YY, Zou JY, Luo HH. Gu Y, et al. Among authors: luo hh. Int J Clin Exp Med. 2015 Mar 15;8(3):3227-33. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26064212 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

158 results

Search Page

Filters